We want to keep momentum going and we need to ensure that those issues raised and discussed are addressed, to create a greater service for people with MS. As a result, we are currently planning the follow-up meeting for 2020. Please register via the button below.
Date: 12 & 13 November 2020
This July, the second in a series of national events to discuss, inspire and instigate action to ‘raise the bar for MS services’ opened with a poll.
Setting the tone for the two-day intensive event, 85% of the 120 healthcare practitioners either agreed or strongly agreed that ‘Those of us in the room have the power we need to fundamentally improve the quality of MS care in the UK, reduce variation and offer consistent care at the level we want everywhere, in the next 3 years’ […] → read more about this meeting
Read more about the idea behind this meeting:
→ Let’s raise the bar for MS Services
Extent of representation 2019:
November 2018 saw our first in a series of events set to tackle MS service variation in the NHS. The event highlighted a number of challenges to improving health and social care, to deliver more equitable and optimised MS services in the UK. It also saw over 110 professionals discuss and agree some of the ways forward, and heard innovative solutions posed.
We at the MS Academy are committed to being part of the change needed to end service variation for multiple sclerosis, and we know how key information sharing and education is to that change.
Part of our role is to share the meeting’s discussions and findings to as wide an audience as possible, and another is to help you all stay aware of the work taking place to end variation, enabling you to get involved wherever you want and need to be.
These ‘Spotlights’ will give you an in-depth look at some of the key issues raised at the first Variance event (November 2018), sharing some of the solutions considered and workstreams begun to make change a reality.
We initially held a debate in May 2018 on whether or not the new NHS England treatment algorithm will reduce variation in the prescribing of DMTs in England. This was followed by a much larger meeting of representatives from MS disease-modifying therapy prescribing centres across the UK, in Birmingham, in early November. The meeting was a great success and generated many ideas and proposals that if implemented could potentially solve the problem of variance in the NHS. We are now planning to hold a subsequent follow-on meeting to implement several of proposals that emerged from this meeting.
Link to previous meeting: 1-2 November 2018, Birmingham